Dror Bashan

Insider Reports History

Location
Carmiel
Signature
/s/ Joseph R. Magnas, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dror Bashan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Protalix BioTherapeutics, Inc. PRESIDENT AND CEO, Director Common Stock 2,344,418 $4,430,950 $1.89 19 Dec 2025 By Trust
Protalix BioTherapeutics, Inc. PRESIDENT AND CEO, Director Common Stock 188,516 $341,213 $1.81 19 Dec 2025 Direct
Protalix BioTherapeutics, Inc. PRESIDENT AND CEO, Director Stock Option (Right to Buy) 340,000 03 Sep 2025 Direct

Insider Reports Filed by Dror Bashan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PLX Protalix BioTherapeutics, Inc. 19 Dec 2025 1 +$101,360 4 PRESIDENT AND CEO, Director 23 Dec 2025, 07:25
PLX Protalix BioTherapeutics, Inc. 03 Sep 2025 2 $0 4 PRESIDENT AND CEO, Director 04 Sep 2025, 17:00
PLX Protalix BioTherapeutics, Inc. 19 Oct 2023 2 +$90,484 4 PRESIDENT AND CEO, Director 20 Oct 2023, 06:50
PLX Protalix BioTherapeutics, Inc. 15 Aug 2023 1 $0 4 President and CEO, Director 17 Aug 2023, 16:30
PLX Protalix BioTherapeutics, Inc. 01 Apr 2023 1 $0 4 PRESIDENT AND CEO, Director 03 Apr 2024, 17:30
PLX Protalix BioTherapeutics, Inc. 07 Sep 2022 1 $0 4 President and CEO, Director 09 Sep 2022, 17:02
PLX Protalix BioTherapeutics, Inc. 11 Apr 2022 1 +$102,000 4 President and CEO, Director 13 Apr 2022, 16:05
PLX Protalix BioTherapeutics, Inc. 25 Feb 2022 1 $0 4 President and CEO, Director 28 Feb 2022, 16:01